Apple awards $10 million to COPAN Diagnostics

Apple Advanced Manufacturing Fund To Copan Diagnostics
Apple Advanced Manufacturing Fund To Copan Diagnostics (Image credit: Apple)

What you need to know

  • Apple has announced it will award $10 million to COPAN Diagnostics
  • The firm specializes in sample collection kits.
  • The money will be used to help fund COVID-19 testing.

Apple has today announced it will award $10 million to COPAN Diagnostics to help fund COVID-19 testing.

In a press release Apple stated:

Cupertino, California — Apple today announced it is awarding $10 million from its Advanced Manufacturing Fund to COPAN Diagnostics, a market leader in sample collection kits that play a critical role in COVID-19 testing. This funding will allow COPAN Diagnostics to rapidly accelerate their supply of sample collection kits for hospitals across the United States, expanding production from several thousand today to more than one million kits per week by early July. As part of this effort, Apple will support COPAN Diagnostics' expansion to a new, larger facility in Southern California, with advanced equipment that Apple is helping design. This expansion is expected to create more than 50 new jobs.

Apple says that it's sourcing equipment and materials for COPAN Diagnostics from companies across the US. COPAN is a "global player in the field of specimen collection and preservation for infectious disease diagnostics." Apple says the company's sample collection kits "have revolutionized the diagnostic industry and play a critical role in the COVID-19 testing process.

Apple's CFO Jeff Williams said:

"We feel a deep sense of responsibility to do everything we can to help medical workers, patients, and communities support the global response to COVID-19. COPAN is one of the world's most innovative manufacturers of sample collection kits for COVID-19 testing, and we're thrilled to partner with them so they can expand as we work to address this critical issue for our nation. I couldn't be prouder of our teams for bringing all of their energy, passion, and innovative spirit to supporting the country's COVID-19 response."

COPAN Diagnostics' CEO Norman Sharples said Apple's teams were already making "a huge difference with our efforts to scale up the production of our sample collection and transport kits," which it says are a "critical component in the fight against COVID-19.

You can read the full press release here.

Stephen Warwick
News Editor

Stephen Warwick has written about Apple for five years at iMore and previously elsewhere. He covers all of iMore's latest breaking news regarding all of Apple's products and services, both hardware and software. Stephen has interviewed industry experts in a range of fields including finance, litigation, security, and more. He also specializes in curating and reviewing audio hardware and has experience beyond journalism in sound engineering, production, and design. Before becoming a writer Stephen studied Ancient History at University and also worked at Apple for more than two years. Stephen is also a host on the iMore show, a weekly podcast recorded live that discusses the latest in breaking Apple news, as well as featuring fun trivia about all things Apple. Follow him on Twitter @stephenwarwick9